CardioGraft® Aortic Valve

CardioGraft® Aortic Valve
CardioGraft® Aortic Valve
A human aortic valve for aortic valve replacement
- Allograft tissue most closely resembles the patient’s native tissue
- The use of human tissue alleviates the need for anticoagulants
- Effective orifice area closely approximates the native valve
- Anterior mitral leaflet retained for use in endocarditis/abscess reconstruction
- Availability in various sizes to best fit the patient’s anatomy
-
Safety: Allografts offer a high resistance to infection
Clinical Application
Aortic Valve Replacement
Cryopreserved | Description | Sizing |
---|---|---|
HVA-S | Aortic Heart Valve | D ≤ 16 mm |
HVA-M | Aortic Heart Valve | D = 17 - 21 mm |
HVA-L | Aortic Heart Valve | D ≥ 22 mm |
References
- Hopkins. Cardiac Reconstructions with Allograft Tissues. Springer, NY, NY. 2005
- Fukushima, Tesar, et al. Long-term clinical outcomes after aortic valve replacement using cryopreserved aortic allograft. Journal of Thoracic and Cardiovascular Surgery, 2014; 148, 1: 65-72.
- Lytle, Pettersson, et al. Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. The Annals of Thoracic Surgery, 2002; 74: 1754-1757.
- Pettersson, Coselli, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis. Journal of Thoracic and Cardiovascular Surgery, 2017; 153: 1241-1258.